Michigan Risk Score for PICC-Related Thrombosis
The Michigan Risk Score predicts a patient’s likelihood of developing PICC‑associated thrombosis using five clinical and device-related risk factors 1.
Indicações de Uso
Used for adult inpatients receiving a new PICC to estimate early symptomatic PICC‑VTE risk and guide device choice or modifiable risk reduction (fewer lumens, delay placement if high WBC). Derived from 22 056 patients, identifying a 0.8% low‑risk vs 6.9% high‑risk VTE rate (OR 8.3) 1 [Level II evidence]. Most useful for avoiding high‑risk PICC placement and targeting closer monitoring.
Insights e Precauções
Start by recognizing that risk rises sharply with prior VTE, multilumen PICC, active cancer, concurrent central catheter, and WBC >12 000/µL, the five validated predictors from a 22 056‑patient cohort (PICCs→VTE 0.8% lowest‑ vs 6.9% highest‑risk; OR 8.3) 1 [Level II evidence].
Use cautiously: derived in Michigan hospitals only, limited external validation, and does not account for key modifiers (chemotherapy type, tip position, catheter‑to‑vein ratio) that strongly influence PICC thrombosis.